share_log

泓博医药(301230.SZ):中富基石拟减持不超1.00%股份

Hengbo Pharmaceutical (301230.SZ): China Wealth Foundation intends to reduce its shareholding by no more than 1.00%.

Gelonghui Finance ·  Sep 2 08:21

As of the date of this announcement, Peking Zhongfu Foundation Investment Center (limited partnership) (hereinafter referred to as "Zhongfu Foundation") holds 6,164,860 shares of the company, accounting for 4.48% of the total share capital after deducting the repurchased shares disclosed in the latest announcement. Together with the Beijing Zhongfu Growth Equity Investment Center (limited partnership), the joint actor holds a total of 8,967,660 shares of the company, accounting for 6.52% of the total share capital after deducting the repurchased shares disclosed in the latest announcement. Zhongfu Foundation plans to reduce its shareholding by no more than 1,370,000 shares within 3 months after 15 trading days from the date of this announcement through centralized bidding and block trading, which is no more than 1.00% of the total share capital after deducting the repurchased shares disclosed in the latest announcement. Among them, the reduction through centralized bidding does not exceed 685,000 shares, which is no more than 0.50% of the total share capital after deducting the shares held in the company's repurchase special account. The reduction through block trading does not exceed 685,000 shares, which is no more than 0.50% of the total share capital after deducting the shares held in the company's repurchase special account.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment